Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-thymocyte globulin, cyclosporine A and low-dose danazol for untreated moderate to severe idiopathic aplastic anemia
KCT0004219Phase 2Not yet recruiting
- Sponsor
- Gachon University Gil Medical Center
- Start
- Sep 2019
- Modality
- Small Molecules, Peptides, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit, cyclosporine, danazol in aplastic anemia, sponsored by Gachon University Gil Medical Center. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
antithymocyte globulin rabbitcyclosporinedanazol
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on KCT0004219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004219.